Discover why Viking Therapeutics, Inc.'s VK2735 could lead GLP-1 obesity drugs. Click for my updated look at VKTX stock following its Q3 earnings release.

MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it will present new Phase 1 and pre-clinical data on DA-1726, a novel, dual ...

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in people who took Wegovy. By Dani Blum A new analysis of a major clinical trial ...

This is an active lawsuit, and none of the allegations against the defendant(s) have been proven. The contents of this page reflect the allegations in the lawsuits. Thousands of patients have filed ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Pregnancy and semaglutide — the active ingredient in GLP-1 drugs such as Ozempic for Type 2 diabetes and Wegovy for weight loss — don’t mix. But what about breastfeeding? Women should stop taking ...

Weight loss drugs such as Ozempic and Wegovy can not only help drop the pounds, now researchers say it can help curtail alcohol intoxication. The drugs can slow down the rate at which alcohol enters ...

Oct 23 (Reuters) - London-based telehealth startup SheMed said on Thursday it raised $50 million in a Series A round, valuing the company at $1 billion, as demand for weight-loss drugs Wegovy and ...

For years, MASH was where drug development dreams went to die. One trial after another failed. Companies bowed out. The field earned a reputation as one of biopharma’s most intractable challenges: a ...

After clearing Novo Nordisk’s semaglutide treatments Ozempic and Wegovy to reduce the risk of major adverse cardiovascular events (MACE), the FDA has followed suit with a MACE expansion for its ...

PLAINSBORO, N.J., and BAGSVÆRD, Denmark, Oct. 20, 2025 /PRNewswire/ -- Novo Nordisk today announced new data on the investigational oral semaglutide 25 mg will be among 23 abstracts to be presented at ...

The price of Novo Nordisk's blockbuster diabetes and weight loss-related drug Ozempic will be cut, according to President Donald Trump. Trump said this week during a White House event on fertility ...